1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
605EB777C0F660F9C65257D0B0020A50C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/05EB777C0F660F9C65257D0B0020A50C!OpenDocument
18
19OpenDocument
2044.201.97.138
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Field Medical Excellence

Complimentary Excerpt: Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment

DB Image

ID: MD-418


Features:

9 Info Graphics

10 Data Graphics

141 Metrics


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5314 "Preparing Medical Science Liaison Teams for a Changing Environment: Team Size and Deployment".

Industries Profiled:
Biotech; Health Care; Pharmaceutical; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Medical Device


Companies Profiled:
Acorda Therapeutics; United Therapeutics; Sanofi; Upsher-Smith; Kadmon Pharmaceuticals; Shire; Crescendo Bioscience; Teva Pharmaceutical Industries Ltd; Lilly; Baxter BioScience; Merck; Cubist Pharmaceuticals; Pierre Fabre Medicament; Amgen; ProStrakan; Dr Reddy's Laboratories; Biocon; Genentech; Astellas; Ironwood; Biogen Idec; AstraZeneca; Covidien

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.